All Curated Mutation Sites in HCMV

Back to Mutation Home

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HCMV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

Click the button below to quickly view the viral genes/regions/protein for mutation

Keyword: Cytomegalovirus infections-31568799

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	31568799	A591V	UL97	UL97	Cytomegalovirus infections	D	View
2	31568799	A594V	UL97	UL97	Cytomegalovirus infections	D	View
3	31568799	A834P	UL54	UL54	Cytomegalovirus infections		View
4	31568799	C592G	UL97	UL97	Cytomegalovirus infections	D	View
5	31568799	C603W	UL97	UL97	Cytomegalovirus infections	D	View
6	31568799	355delK	UL97	UL97	Cytomegalovirus infections		View
7	31568799	F342S	UL97	UL97	Cytomegalovirus infections	D	View
8	31568799	F342Y	UL97	UL97	Cytomegalovirus infections	D	View
9	31568799	H411Y	UL97	UL97	Cytomegalovirus infections	D	View
10	31568799	H520Q	UL97	UL97	Cytomegalovirus infections	D	View
11	31568799	K359E	UL97	UL97	Cytomegalovirus infections	D	View
12	31568799	K359Q	UL97	UL97	Cytomegalovirus infections	D	View
13	31568799	L595S	UL97	UL97	Cytomegalovirus infections	D	View
14	31568799	M460I	UL97	UL97	Cytomegalovirus infections	D	View
15	31568799	M460V	UL97	UL97	Cytomegalovirus infections	D	View
16	31568799	T409M	UL97	UL97	Cytomegalovirus infections	D	View
17	31568799	V823A	UL54	UL54	Cytomegalovirus infections		View

Contents
Description

The table shows all curated mutation sites of HCMV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.